⌘K

Login Start Free

Home/Filings/4/0001104659-11-053334

4//SEC Filing

McBarron Paul 4

Accession 0001104659-11-053334

CIK 0001130166other

View on SEC.gov Company Profile

Filed

Sep 25, 8:00 PM ET

Accepted

Sep 26, 8:45 PM ET

Size

4.8 KB

Accession

0001104659-11-053334

Insider Transaction Report

Form 4

Period: 2011-09-23

Cyclacel Pharmaceuticals, Inc.CYCC

DirectorEVP, Finance, CFO, COO

Transactions

Purchase
Common Stock, $0.001 par value per share
2011-09-23$0.50/sh+12,000$6,000→ 188,054 total

Footnotes (1)

[F1]Includes 14,576 shares of restricted stock subject to forfeiture until vested.

Documents

1 file

4
a4.xmlPrimary
4

Issuer

Cyclacel Pharmaceuticals, Inc.

CIK 0001130166

Entity typeother

Related Parties

1

filerCIK 0001357397

Filing Metadata

Form type: 4
Filed: Sep 25, 8:00 PM ET
Accepted: Sep 26, 8:45 PM ET
Size: 4.8 KB

View on SEC.gov